Navigation Links
Transporter offers reliable clues for safer pain medicine

Researchers have zeroed in on a transporter that actually quietens the body’s natural pain killers. This discovery will show the way for potent and non-habit //forming pain killers and will help perceive the pain threshold of AIDS patients.

Opioid peptides are natural pain relievers with receptors – first identified because they react to opium – throughout the body, says Dr. Vadivel Ganapathy, chair of the Department of Biochemistry and Molecular Biology at the Medical College of Georgia. Studies have shown, for example, opioid peptide levels increase during childbirth.

Many potent pain killers, such as morphine and codeine, override this natural pain control system by directly activating opioid peptide receptors. While pain control is effective, it comes at a price: potential addiction, immune suppression and constipation.

Now researchers want to know whether safer pain killers can be developed that augment the body’s natural pain-killing ability by targeting instead the opioid peptide transport system that terminates pain-control communication, says Dr. Ganapathy. 'This has the potential for non-addictive pain killers that are effective, but by a different mechanism.'

Many popular antidepressants work in a similar fashion to keep the body’s natural chemical messengers, called neurotransmitters, working longer by keeping them from being taken back up into the neuron by transport systems. Chemical messengers are supposed to have limited action, he says. But depressed patients have insufficient levels of chemicals for adequate communication between neurons. Antidepressants provide more mileage from existing neurotransmitters.

Dr. Ganapathy hopes to do the same with endogenous pain killers. Armed with a two-year, $286,000 grant from the National Institute on Drug Abuse, he is working to clone the opioid peptide transporter he identified three years ago and identify the responsible gene and protein.

Interestingly he also has found mice expressing one of the HIV proteins have increased activity of this transporter, a finding that might help explain why HIV patients have increased pain perception. 'That means the normal endogenous activity of this transport system is higher in HIV patients, so natural pain mechanisms are not working that well,' says Dr. Ganapathy.

The National Institute on Drug Abuse asked him to apply for the Cutting Edge Basic Research Grant – which enables quick review for funding of novel ideas – to pursue this hypothesis as well as the molecular analysis of the transporter.

The idea that a transport system is involved is itself a novel concept. Conventional wisdom was that an enzyme was responsible for hydrolyzing, or decomposing, opioid peptide, Dr. Ganapathy says. This is the case for at least one neurotransmitter – acetylcholine, implicated in Alzheimer’s - which is inactivated by an enzyme, rather than being transported back into the neuron like other neurotransmitters, such as serotonin, which has a role in depression.

But when he watched the activity of opioid peptides, he saw it actively taken back up into the neuronal cells.

Cloning the transporter and dissecting its molecular profile will ultimately provide a model for studying whether naturally occurring or designer drugs block this re-uptake. In fact, the National Institute on Drug Abuse will provide Dr. Ganapathy with a number of synthetic opioid peptides to see whether they are substrates, or blockers, of this transport system.

'We know this recognizes peptides. Therefore, any chemical compound that will block the transport function must have some resemblance to its natural substrate. Otherwise, it might not do the job,' Dr. Ganapathy says.

He’s already testing naturally occurring amino acids and peptides and found one – lysine, an essential amino acid vital to good growth and found in high concentrations in red meat, cheeses, poultry, sardines, nuts, eggs and soybeans – that’s a pretty good fit.

'We may be able to take this compound as a starting point, then add a few things to make it more effective. You could have a lysine-based drug for the treatment of pain, maybe even a nutritional supplement to prevent pain,' says Dr. Ganapathy. 'You could use such a treatment to block this transport activity for HIV patients as well as other patients to control pain.'

(Souce:Eureka)
'"/>




Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Magnesium sulfate offers no help in migraine treatment
4. ESRC offers new dynamics for old in UK
5. Roche offers HIV drug expertise to poor nations
6. Genetically modified Lactic acid bacteria offers HIV protection
7. SRL Ranbaxy offers quicker bird flu diagnostic test
8. Victorian Initiative: Coffers Are Ringing For an Upcoming Cancer Agency
9. Kidney Disease Is Milking the Government Coffers - Is Australia Notorious for High Rates of Kidney Disease?
10. Fermented Milk offers protection against allergies in infants
11. Tegaserod offers relief for Chronic Constipation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest Obamacare ... Bill Cassidy (R-LA) and Lindsey Graham ... that the medical device industry is in an odd ... tax, the 2.3% excise tax on medical device sales ... also want covered patients, increased visits and hospital customers ...
Breaking Medicine Technology: